@misc{indiciaef7d83a7ab1ac,
  title = {NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma},
  author = {Hu, C. and Lin, W. and Zhao, K. and Tian, G. and Kong, X. and Luo, G. and Wolf, D. A. and Cheng, Y.},
  year = {2023},
  doi = {10.1101/2023.03.07.531634},
  url = {https://www.biorxiv.org/content/10.1101/2023.03.07.531634v1},
  note = {Source identifier: 10.1101/2023.03.07.531634}
}